Universitätsklinikum Hamburg-Eppendorf: Sclerosis trials

The registry lists 10 Sclerosis studies with Universitätsklinikum Hamburg-Eppendorf as lead sponsor. 1 are open to participants now and 1 have results posted.

Phase 1 1Phase 2 3No phase 7(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Patient Experiences of Multiple Sclerosis (PExMS)Not yet recruitingNCT04236544Not applicable
• Establish Tolerance In MS With Peptide-Coupled, Peripheral Blood Mononuclear CellsCompletedNCT01414634Phase 1/2Results posted
• Ocrelizumab or Alemtuzumab Compared With Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis - a Phase-2 Randomised Controlled TrialTerminatedNCT04971005Phase 2
• Development and Evaluation of a Web-based Programme on Relapse Management for People With Multiple SclerosisCompletedNCT04233970Not applicable
• Interactive Web Platform for EmPOWERment in Early Multiple SclerosisCompletedNCT03968172Not applicable
• Understanding Magnetic Resonance Imaging in Multiple SclerosisCompletedNCT03872583Not applicable
• Effects of Fingolimod on Heart Rhythm and Heart Rate Variability in Patients With Multiple SclerosisStatus unknownNCT03216915
• Armergometry to Improve Mobility in MSStatus unknownNCT03147105Not applicable
• Exercise in Multiple Sclerosis: Effects on Cognitive Function and Brain ConnectivityCompletedNCT02005237Not applicable
• Safety, Tolerability And Mechanism Of Action Of Boswellic Acids (BA) In Multiple Sclerosis (SABA)CompletedNCT01450124Phase 2